ArticleJournal of clinical apheresis2025
Performance of Total Blood Volume Algorithms in Obesity and Severe Obesity.
Article in Journal of clinical apheresis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach From the Writing Committee of the American Society for Apheresis: The Tenth Special Issue.Journal of clinical apheresis · 2026Guideline
- Preoperative Hemoglobin and Body Mass Index as Predictors of Safe Aspirate Volume in Liposuction.Plastic and reconstructive surgery. Global open · 2026Article
- Obesity and Pharmacokinetic Variability: Implications for Cardiovascular Therapeutics.European cardiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Amid the ongoing obesity epidemic, the estimation of total blood volume (TBV) in obese people remains hotly contested without common agreement among apheresis practitioners. We compare the results of estimated TBV from different formulas across a spectrum of obese BMIs from a cohort of 155 individual patients. We also plot the difference between the resulting TBVs, assigning a threshold of functional significance of 500 mL, at which the choice of formula might make an impact on patient care. We compare the mean TBV estimated in non-severe versus severe obesity for all the above algorithms and determine the impact of algorithm choice on various apheresis procedures. The choice of algorithm has a significant impact on apheresis procedures; for example, we found differences of up to ~3-4 plasma units for a therapeutic plasma exchange depending on the choice of algorithm applied. We additionally find that algorithm performance varies widely in both men and women, particularly in morbid obesity, and often produces values that fall outside an empirically chosen expected range. We do not find a clinically significant difference in mean estimated TBV between non-severe and severe obesity in any algorithm tested, suggesting that physiological changes in obesity may fail to be captured by these algorithms. We hope these results are useful to other apheresis practitioners and help them make an informed choice of algorithm to estimate TBV in their obese patients. However, our current algorithms for estimating TBV may be flawed, and the field may wish to move toward measurement of TBV using recently available commercial options.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.